Immunologic adjuvant

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugate includes potentiator; or composition comprising...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 5, 536 18, 536 53, 536122, A61K 31575, C07J 900

Patent

active

043011527

ABSTRACT:
Immunologic adjuvants are obtained by the synthesis of 6-(5-cholesten-3.beta.-yloxy)hexyl 6-amino-6-deoxy-1-thio-.beta.-D-galactopyranoside and its 6-deoxy-6-oleamido derivative.

REFERENCES:
patent: 2216617 (1940-10-01), Katz
patent: 4131732 (1978-12-01), Hill et al.
patent: 4189471 (1980-02-01), Ponpipom et al.
Noller, "Chemistry of Organic Compounds", 3rd Ed., W. B. Saunders Co., Phila., Pa., p. 604.
Behling et al., "Jour. of Immunology", vol. 117, No. 3, Sep. 1976, pp. 847-851.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunologic adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunologic adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunologic adjuvant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1292341

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.